Elizabeth Berry-Kravis

Professor
Rush University Medical Center

Elizabeth Berry-Kravis is professor of child neurology at Rush University Medical Center in Chicago.

From this contributor

By Jessica Wright

26 February 2019

6 min read

Analysis offers new hope for failed fragile X drug

Eye tracking shows that mavoglurant, a once-abandoned experimental drug for fragile X syndrome, enters the brain and boosts social interest, says Elizabeth Berry-Kravis.

Spectrum

Analysis offers new hope for failed fragile X drug

By Jessica Wright

26 February 2019 | 6 min read

Spectrum

By Jessica Wright

24 May 2016

6 min read

Questions for Elizabeth Berry-Kravis: Dodging mouse traps

A mouse model of fragile X syndrome lacks a key feature of the condition, prompting researchers to look for other ways to test treatments.

Spectrum

Questions for Elizabeth Berry-Kravis: Dodging mouse traps

By Jessica Wright

24 May 2016 | 6 min read

Spectrum

By Nicholette Zeliadt

17 February 2015

5 min read

Questions for Elizabeth Berry-Kravis: Measuring drug effects

Drugs designed to treat fragile X syndrome have yet to show substantial benefits in people. But rather than abandon them, child neurologist Elizabeth Berry-Kravis suggests a new way to measure their effectiveness.

Spectrum

Questions for Elizabeth Berry-Kravis: Measuring drug effects

By Nicholette Zeliadt

17 February 2015 | 5 min read

Explore more from The Transmitter

Treatments

By Calli McMurray

2 June 2026

5 min read

Research image of brain cells involved with Amyotrophic lateral sclerosis (ALS) illuminated through genetic tools

Allen Institute sets sights on treatments for five brain diseases

The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.

Treatments